Does low 25-hydroxyvitamin D impair immune regulation and raise thyroid autoantibodies?

Vitamin D plays a critical role in maintaining immune tolerance, and its deficiency is consistently linked to the progression of autoimmune thyroid diseases (AITD), such as Hashimoto’s thyroiditis and Graves’ disease. Current evidence suggests that low levels of 25-hydroxyvitamin D [25(OH)D] are associated with both impaired immune regulatory mechanisms and elevated titers of thyroid-specific autoantibodies.

Clinical effectiveness and antibody levels

Observational data and meta-analyses establish a clear inverse relationship between serum vitamin D and thyroid autoimmunity.

• Prevalence of deficiency: Patients with AITD exhibit significantly lower vitamin D levels compared to healthy individuals. Studies report deficiency rates of 62–70% in newly diagnosed AITD cases, compared to 26–51% in control groups.
• Impact of supplementation: Meta-analyses of 8 to 12 randomized controlled trials (RCTs) demonstrate that vitamin D supplementation effectively reduces Thyroid Peroxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb). Significant reductions have been observed, with standardized mean differences (SMD) ranging from -1.08 to -1.11 for TPOAb and -0.99 to -1.12 for TgAb. These improvements are most notable in patients with baseline deficiency (<20 ng/mL) treated for at least three months.

Mechanistic explanations

The association is driven by the role of the vitamin D receptor (VDR) in modulating the adaptive immune response.

• T-cell differentiation: Inactive 25(OH)D is converted by antigen-presenting cells into its active form, which signals through the VDR to promote an anti-inflammatory environment. It enhances the differentiation of regulatory T cells (Tregs) and increases the production of the anti-inflammatory cytokine IL-10.
• Loss of tolerance: Low vitamin D levels correlate with a pro-inflammatory shift, characterized by a decrease in Treg-mediated suppression and an increase in Th17 activity. This imbalance leads to a failure in self-tolerance, facilitating the production of autoantibodies against thyroid tissue.

Bottom line

Low 25-hydroxyvitamin D is a plausible driver of thyroid autoimmunity by impairing immune regulation and is strongly associated with higher thyroid autoantibody levels. Supplementation can significantly lower antibody titers, particularly in individuals with established deficiency.